Personal Clinical Research Services financials
A multi-period view of the public annual-account figures reported for Personal Clinical Research Services, with comparable measures and links to available source documents.
Company overviewRegistry number
0643726543
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Personal Clinical Research Services
2025 versus 2024
- Operating line
- €96,415
- EBITDA
- €95,609
- Total assets
- €539,972
- Equity
- €184,373
-18.2%
-17.9%
-7%
+3.7%
EBITDA margin +99.2% · Equity ratio +34.1%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €96,415 | €95,609 | €539,972 | €184,373 | - |
| 202431 Dec 2024 | €117,836 | €116,401 | €580,629 | €177,762 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.